Tubulocystic renal cell carcinoma: Is there a rational reason for targeted therapy using angiogenic inhibition? Analysis of seven cases
10.1007/s00428-012-1367-z
Saved in:
Main Authors: | Steiner, P., Hora, M., Stehlik, J., Martinek, P., Vanecek, T., Petersson, F., Michal, M., Korabecna, M., Travnicek, I., Hes, O. |
---|---|
Other Authors: | PATHOLOGY |
Format: | Article |
Published: |
2016
|
Subjects: | |
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/125641 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Review of tubulocystic carcinoma of the kidney with focus on clinical and pathobiological aspects
by: Kuroda, N., et al.
Published: (2016) -
Tubulocystic renal carcinoma: A clinical perspective
by: Hora, M., et al.
Published: (2016) -
Functionalized nanoceria exhibit improved angiogenic properties
by: Nethi, Susheel Kumar, et al.
Published: (2020) -
Biphasic alveolosquamoid renal carcinoma: A histomorphological, immunohistochemical, molecular genetic, and ultrastructural study of a distinctive morphologic variant of renal cell carcinoma
by: Petersson, F., et al.
Published: (2016) -
The leiomyomatous stroma in renal cell carcinomas is polyclonal and not part of the neoplastic process
by: Petersson, F., et al.
Published: (2016)